85-2070-82　［取扱停止］15-PGDH Inhibitor (5-(4-(2-Cyclohexylethoxy)-3-methoxybenzylidene)thiazolidine-2,4-dione) 10mg　217116

特徴

• A cell-permeable, thiazolidinedione derivative that acts as a 15-hydroxyprostaglandin dehydrogenase (15-PGDH) inhibitor (IC50=25nM). It is shown to increase PGE2 levels in IL-1b-stimulated A549 cells, dose-dependently, in the range of 0-20uM, and elicits cochlear blood flow (CBF) increase by 15% and 55% when applied intravenously to 250g guinea pigs at 10ug and 20ug respectively.
• Synonyms:5-(4-(2-Cyclohexylethoxy)-3-methoxybenzylidene)thiazolidine-2,4-dione
• Formula:C19H23NO4S
• Molecular Weight:361.5
• Solubility:DMSO (100mg/ml, clear, pale yellow solution)
• Storage and Stability:Store at -20°C under inert atmosphere. For maximum recovery of product, centrifuge the original vial prior to removing the cap.

仕様

• Size：10mg
• Grade：Highly Purified
• Purity：~99% (HPLC)
• Form：Supplied as a yellow solid.
• Molecular Formula：C19H23NO4S
• Molecular Weight Non Ab：361.5
• EU Commodity Code：38220090
• この商品は法規制を確認しておりません。(法規制によって販売できない場合もございます)
• 製品の仕様は予告なく変更になる場合がございます。最新仕様はメーカーホームページをご確認ください。

• 【試薬に関するお問合せ】
• アズワン株式会社 試薬・プロセス材料グループ
• TEL：06-6447-8641
• FAX：06-6447-8642
• E-mail：[email protected]